2011
DOI: 10.3906/kim-1010-732
|View full text |Cite
|
Sign up to set email alerts
|

Stable ester and amide conjugates of some NSAIDs as analgesic and antiinflammatory compounds with improved biological activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…However, long-term reception of NSAIDs weakens their activity owing to gastrointestinal and renal side effects due to a combination of local irritations produced by their free carboxyl group and by suppression of the cytoprotective prostaglandins on gastric mucosa. 2 Magnetic nanoparticles (MNPs) offer bimodal and/or multiple capabilities in clinical use 3 due to the ability to perform as contrast agents in magnetic resonance imaging and/or in magnetic hyperthermia, whereas they are proposed as drug carriers in order to surpass the limitations that drugs undergo due to poor targeting or cytotoxicity and decreased efficacy. To our knowledge, the use of MNPs as NSAIDs carriers has not been given much attention.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, long-term reception of NSAIDs weakens their activity owing to gastrointestinal and renal side effects due to a combination of local irritations produced by their free carboxyl group and by suppression of the cytoprotective prostaglandins on gastric mucosa. 2 Magnetic nanoparticles (MNPs) offer bimodal and/or multiple capabilities in clinical use 3 due to the ability to perform as contrast agents in magnetic resonance imaging and/or in magnetic hyperthermia, whereas they are proposed as drug carriers in order to surpass the limitations that drugs undergo due to poor targeting or cytotoxicity and decreased efficacy. To our knowledge, the use of MNPs as NSAIDs carriers has not been given much attention.…”
Section: Introductionmentioning
confidence: 99%
“…The main role of NSAIDs is to block the formation of prostaglandins with the inhibition of the enzymes responsible for their production (i.e., cyclooxygenases, COX). However, long-term reception of NSAIDs weakens their activity owing to gastrointestinal and renal side effects due to a combination of local irritations produced by their free carboxyl group and by suppression of the cytoprotective prostaglandins on gastric mucosa …”
Section: Introductionmentioning
confidence: 99%
“…Ning and co-workers report the synthesis and characterization of the fluorinated product of compound 3a [40]. The second reported by us, molecule 3b, partially consists of the molecule reported by a group of Turkish scientists [41]. There was no information available in chemical databases for compounds 3c and 3d.…”
Section: Synthesismentioning
confidence: 99%
“…1,2,5,6 In order to minimize side effects, improve analgesic/anti-inflammatory activity, a number of NSAID derivatives were prepared and some of them were reported to have better bioavailability, less gastric irritation and improved anti-oxidant property etc. [7][8][9][10][11] Naproxen, a nonselective NSAID presents the least cardiovascular risk and provides the most effective relief for arthritic patients among all NSAIDs. 12 However, arthritic doses of naproxen are significantly toxic to the GI tract resulting from COX-1 inhibition.…”
Section: Introductionmentioning
confidence: 99%